Source comparison
Biomarkers That Indicate Effective GH Restoration vs Overstimulation
Anti-aging research isn't about maximizing GH or IGF-1. It's about restoring age-appropriate pulsatility. The target IGF-1 range for a 55-year-old isn't the same as for a 25-year-old. Effective protocols in aging populations aim for IGF-1 levels in the 180–240
This comparison does not assign a generated winner or score.
- Anti-aging research isn't about maximizing GH or IGF-1. It's about restoring age-appropriate pulsatility. The target IGF-1 range for a 55-year-old isn't the same as for a 25-year-old. Effective protocols in aging populations aim for IGF-1 levels in the 180–240 ng/mL range (measured via LC-MS, not immunoassay), which corresponds to the upper-middle range for healthy adults aged 50–60. Levels above 280 ng/mL indicate supraphysiological stimulation and correlate with increased insulin resistance, as documented in the Framingham Heart Study's metabolic substudy.
- Fasting glucose and HbA1c are secondary markers. Sustained GH elevation impairs insulin signaling at the hepatic and peripheral tissue level, raising fasting glucose by 8–15 mg/dL within 4–6 weeks. CJC-1295 no DAC combined with Ipamorelin, dosed in the evening to align with natural nocturnal GH secretion, shows minimal glucose dysregulation in published trials. HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) should remain stable or improve slightly as lean mass increases. If HOMA-IR rises above 2.5 in a previously insulin-sensitive individual, the protocol is overstimulating. Sleep quality and REM duration. Measured objectively via polysomnography or consumer-grade sleep trackers. Improve within 2–3 weeks when pulsatility is restored correctly, because GH pulses during deep sleep stages trigger restorative processes.